nach oben

Current Psychiatry Reports

Erschienen in:

01.01.2019 | Child and Adolescent Disorders (T Benton, Section Editor)

Obesity in Adolescents with Psychiatric Disorders

verfasst von: Ariana M. Chao, Thomas A. Wadden, Robert I. Berkowitz

Erschienen in: Current Psychiatry Reports | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This narrative review synthesized recent research related to obesity in adolescents with psychiatric disorders, with a focus on epidemiology, mechanisms, and weight management approaches. The paper reviews literature on depressive and anxiety disorders, bipolar disorder, and schizophrenia spectrum and other psychotic disorders.

Recent Findings

Depression has a bidirectional relationship with obesity. Bipolar disorder and schizophrenia spectrum disorders, and their treatments, increase the risk of developing obesity. Mechanisms underlying this weight gain include lifestyle and environmental factors and psychiatric medications, though emerging evidence has also suggested the role of genetic and neuroendocrine processes. Evidence about the most effective treatments for obesity in adolescents with psychiatric disorders remains limited.

Summary

Adolescents with psychiatric disorders are at high risk for obesity. Close monitoring for increases in weight and cardiometabolic risk factors with use of antipsychotic and mood-stabilizing medications is recommended. Clinical trials are needed that test the efficacy of weight management strategies for this population.

Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–41.PubMedPubMedCentral

Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease—a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137.PubMedPubMedCentral

Ösby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844–50.PubMed

Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.PubMed

Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis. 2003;191(12):799–805.PubMed

Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36(4):341–50.PubMed

Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017.

Centers for Disease Control Prevention. Clinical Growth Charts. 2017. https://www.cdc.gov/growthcharts/clinical_charts.htm. Accessed July 26 2018.

Simmonds M, Llewellyn A, Owen C, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17(2):95–107.PubMed

10.

Ode KL, Frohnert BI, Nathan BM. Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord. 2009;10(3):167–88.PubMedPubMedCentral

11.

Güngör NK. Overweight and obesity in children and adolescents. J Clin Res Pediatr Endocrinol. 2014;6(3):129–43.PubMed

12.

Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373(14):1307–17.PubMed

13.

Xanthopoulos MS, Gallagher PR, Berkowitz RI, Radcliffe J, Bradford R, Marcus CL. Neurobehavioral functioning in adolescents with and without obesity and obstructive sleep apnea. Sleep. 2015;38(3):401–10.PubMedPubMedCentral

14.

Nadeau KJ, Maahs DM, Daniels SR, Eckel RH. Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol. 2011;8(9):513–25.PubMedPubMedCentral

15.

Fleischhaker C, Heiser P, Hennighausen K, Herpertz-Dahlmann B, Holtkamp K, Mehler-Wex C, et al. Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone. J Neural Transm. 2008;115(11):1599–608.PubMed

16.

Marmorstein NR, Iacono WG, Legrand L. Obesity and depression in adolescence and beyond: reciprocal risks. Int J Obes. 2014;38(7):906–11.

17.

•• Quek YH, Tam WW, Zhang MW, Ho R. Exploring the association between childhood and adolescent obesity and depression: a meta-analysis. Obes Rev. 2017;18(7):742–54 This meta-analysis includes 18 observational studies examining the relationship between obesity and depression. PubMed

18.

•• Mannan M, Mamun A, Doi S, Clavarino A. Prospective associations between depression and obesity for adolescent males and females—a systematic review and meta-analysis of longitudinal studies. PLoS One. 2016;11(6):e0157240 This meta-analysis includes 13 longitudinal studies assessing the bidirectional relationship between obesity and depression.PubMedPubMedCentral

19.

Zeller MH, Reiter-Purtill J, Jenkins TM, Ratcliff MB. Adolescent suicidal behavior across the excess weight status spectrum. Obesity. 2013;21(5):1039–45.PubMed

20.

van Dam RM, Willett WC, Manson JE, Hu FB. The relationship between overweight in adolescence and premature death in women. Ann Intern Med. 2006;145(2):91–7.PubMed

21.

Roberts RE, Duong HT. Do anxiety disorders play a role in adolescent obesity? Ann Behav Med. 2016;50(4):613–21.PubMed

22.

Jensen KG, Correll CU, Rudå D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, et al. Pretreatment cardiometabolic status in youth with early-onset psychosis: baseline results from the TEA trial. J Clin Psychiatry. 2017;78(8):e1035–e46.PubMed

23.

• Bioque M, García-Portilla MP, García-Rizo C, Cabrera B, Lobo A, González-Pinto A, et al. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. Schizophr Res. 2018;193:188–96 This study examined weight gain and metabolic changes in a cohort of patients with FEP over 2 years.PubMed

24.

Calkin C, Van De Velde C, Růžičková M, Slaney C, Garnham J, Hajek T, et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord. 2009;11(6):650–6.PubMedPubMedCentral

25.

McElroy SL, Kemp DE, Friedman ES, Reilly-Harrington NA, Sylvia LG, Calabrese JR, et al. Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand. 2016;133(2):144–53.PubMed

26.

• Goldstein BI, Blanco C, He J-P, Merikangas K. Correlates of overweight and obesity among adolescents with bipolar disorder in the National Comorbidity Survey–Adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2016;55(12):1020–6 This study examines the relationship of overweight/obesity in a nationally representaive sample of adolescents with bipolar disorder, major depressive disorder, and control using face-to-face surveys.PubMed

27.

Hu C, Torres IJ, Qian H, Wong H, Halli P, Dhanoa T, et al. Trajectories of body mass index change in first episode of mania: 3-year data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord. 2017;208:291–7.PubMed

28.

Shapiro J, Mindra S, Timmins V, Swampillai B, Scavone A, Collinger K, et al. Controlled study of obesity among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2017;27(1):95–100.PubMed

29.

Mooreville M, Shomaker LB, Reina SA, Hannallah LM, Cohen LA, Courville AB, et al. Depressive symptoms and observed eating in youth. Appetite. 2014;75:141–9.PubMedPubMedCentral

30.

O’Neil A, Quirk SE, Housden S, Brennan SL, Williams LJ, Pasco JA, et al. Relationship between diet and mental health in children and adolescents: a systematic review. Am J Public Health. 2014;104(10):e31–42.PubMedPubMedCentral

31.

Skinner HH, Haines J, Austin SB, Field AE. A prospective study of overeating, binge eating, and depressive symptoms among adolescent and young adult women. J Adolesc Health. 2012;50(5):478–83.PubMed

32.

Martin K, Woo J, Timmins V, Collins J, Islam A, Newton D, et al. Binge eating and emotional eating behaviors among adolescents and young adults with bipolar disorder. J Affect Disord. 2016;195:88–95.PubMed

33.

Hoare E, Millar L, Fuller-Tyszkiewicz M, Skouteris H, Nichols M, Malakellis M, et al. Depressive symptomatology, weight status and obesogenic risk among Australian adolescents: a prospective cohort study. BMJ Open. 2016;6(3):e010072.PubMedPubMedCentral

34.

Castillo F, Francis L, Wylie-Rosett J, Isasi CR. Depressive symptoms are associated with excess weight and unhealthier lifestyle behaviors in urban adolescents. Child Obes. 2014;10(5):400–7.PubMedPubMedCentral

35.

Goldfield GS, Murray M, Maras D, Wilson AL, Phillips P, Kenny GP, et al. Screen time is associated with depressive symptomatology among obese adolescents: a HEARTY study. Eur J Pediatr. 2016;175(7):909–19.PubMed

36.

Rankin J, Matthews L, Cobley S, Han A, Sanders R, Wiltshire HD, et al. Psychological consequences of childhood obesity: psychiatric comorbidity and prevention. Adolesc Health Med Ther. 2016;7:125–46.PubMedPubMedCentral

37.

Kaushik A, Kostaki E, Kyriakopoulos M. The stigma of mental illness in children and adolescents: a systematic review. Psychiatry Res. 2016;243:469–94.PubMed

38.

Stevens SD, Herbozo S, Morrell HE, Schaefer LM, Thompson JK. Adult and childhood weight influence body image and depression through weight stigmatization. J Health Psychol. 2017;22(8):1084–93.PubMed

39.

Quinlan NP, Hoy MB, Costanzo PR. Sticks and stones: the effects of teasing on psychosocial functioning in an overweight treatment-seeking sample. Soc Dev. 2009;18(4):978–1001.PubMedPubMedCentral

40.

Gerke CK, Mazzeo SE, Stern M, Palmberg AA, Evans RK, Wickham EP III. The stress process and eating pathology among racially diverse adolescents seeking treatment for obesity. J Pediatr Psychol. 2013;38(7):785–93.PubMedPubMedCentral

41.

Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N, et al. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med. 2015;45(1):11–27.PubMed

42.

Puhl RM, Peterson JL, Luedicke J. Parental perceptions of weight terminology that providers use with youth. Pediatrics. 2011;128(4):e786–93.PubMed

43.

Raben AT, Marshe VS, Chintoh A, Gorbovskaya I, Müller DJ, Hahn M. The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment. Front Neurosci. 2017;11:741.PubMed

44.

•• Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M et al. First-and second-generation antipsychotics in children and young adults: systematic review update. Rockville (MD): Agency for Healthcare Research and Quality; 2017 Contract No.: 17-EHC001-EF. This provides a comprehensive review of first-and second generation antipsychotics in children and young adults.

45.

Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–23.PubMed

46.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T, Canadian Alliance for Monitoring Effectiveness, et al. Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth. Paediatr Child Health. 2011;16(9):575–80.PubMedPubMedCentral

47.

Bushe CJ, Slooff CJ, Haddad PM, Karagianis JL. Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database. J Clin Psychiatry. 2012;73(6):e749–55.PubMed

48.

•• Pillay J, Boylan K, Newton A, Hartling L, Vandermeer B, Nuspl M et al. Harms of antipsychotics in children and young adults: a systematic review update. Can J Psychiatry. 2018. This included 135 studies on the harms of first- and second-generation treatment of psychiatric conditions in youth, and includes a review of these medications on weight gain.

49.

Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, DeThomas C, Kafantaris V, et al. Clozapine and “high-dose” olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry. 2008;63(5):524–9.PubMed

50.

Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765–73.PubMedPubMedCentral

51.

Martínez-Ortega JM, Funes-Godoy S, Díaz-Atienza F, Gutiérrez-Rojas L, Pérez-Costillas L, Gurpegui M. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. Eur Child Adolesc Psychiatry. 2013;22(8):457–79.PubMed

52.

• Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Chaimani A, et al. Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis. Eur Neuropsychopharmacol. 2018;28(6):659–74 This network meta-analysis synthesizes data from 28 randomized controlled trials comparing symptoms of schizophrenia in youth including weight gain.PubMed

53.

Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004;161(3):414–25.PubMed

54.

Bai YM, Lin C-C, Chen J-Y, Lin C-Y, Su T-P, Chou P. Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry. 2006;163(7):1276–9.PubMed

55.

Kemp DE, Correll CU, Tohen M, DelBello MP, Ganocy SJ, Findling RL, et al. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia. J Child Adolesc Psychopharmacol. 2013;23(8):522–30.PubMedPubMedCentral

56.

Srihari VH, Phutane VH, Ozkan B, Chwastiak L, Ratliff JC, Woods SW, et al. Cardiovascular mortality in schizophrenia: defining a critical period for prevention. Schizophr Res. 2013;146(1):64–8.PubMedPubMedCentral

57.

Zhang J-P, Lencz T, Zhang RX, Nitta M, Maayan L, John M, et al. Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr Bull. 2016;42(6):1418–37.PubMedPubMedCentral

58.

Jerrell JM, McIntyre RS. Metabolic, digestive, and reproductive adverse events associated with antimanic treatment in children and adolescents: a retrospective cohort study. Prim Care Companion J Clin Psychiatry. 2010;12(4):e1–8.

59.

Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry. 2007;46(6):687–700.PubMed

60.

Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69(5):515–28.PubMed

61.

Reekie J, Hosking S, Prakash C, Kao KT, Juonala M, Sabin M. The effect of antidepressants and antipsychotics on weight gain in children and adolescents. Obes Rev. 2015;16(7):566–80.PubMed

62.

Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003;290(8):1033–41.PubMed

63.

Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009;48(7):721–9.PubMed

64.

Schwartz BS, Glass TA, Pollak J, Hirsch AG, Bailey-Davis L, Moran TH, et al. Depression, its comorbidities and treatment, and childhood body mass index trajectories. Obesity. 2016;24(12):2585–92.PubMed

65.

Cockerill RG, Biggs BK, Oesterle TS, Croarkin PE. Antidepressant use and body mass index change in overweight adolescents: a historical cohort study. Innov Clin Neurosci. 2014;11(11–12):14–21.PubMedPubMedCentral

66.

Blumenthal SR, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M, et al. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry. 2014;71(8):889–96.PubMed

67.

Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2):119–36.PubMedPubMedCentral

68.

Afari N, Noonan C, Goldberg J, Roy-Byrne P, Schur E, Golnari G, et al. Depression and obesity: do shared genes explain the relationship? Depress Anxiety. 2010;27(9):799–806.PubMedPubMedCentral

69.

Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. 2017;7(1):e1007.PubMedPubMedCentral

70.

Milaneschi Y, Lamers F, Peyrot WJ, Baune BT, Breen G, Dehghan A, et al. Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations. JAMA Psychiatry. 2017;74(12):1214–25.PubMedPubMedCentral

71.

Zelinski EL, Deibel SH, McDonald RJ. The trouble with circadian clock dysfunction: multiple deleterious effects on the brain and body. Neurosci Biobehav Rev. 2014;40:80–101.PubMed

72.

Lu X-Y. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 2007;7(6):648–52.PubMedPubMedCentral

73.

Lopresti AL, Drummond PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;45:92–9.

74.

Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, et al. Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth. Can J Psychiatry. 2017;62(9):635–47.PubMedPubMedCentral

75.

•• The National Institute for Health and Care Excellence. Psychosis and schizophrenia in children and young people: recognition and management. 2013. https://www.nice.org.uk/guidance/cg155. Accessed July 26 2018. These are clinical guidelines about the management of psychosis and schizophrenia in children and young people.

76.

Sussex Partnership of the NHS. Guidance on the Use of Antipsychotics. 2015. http://www.sussexpartnership.nhs.uk/sites/default/files/documents/antipsychotic_guidelines_version_3.2_-_oct_15_-_with_new_hdat_form_added_-_dec_16_0.pdf. Accessed July 26 2018.

77.

McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):107–25.PubMed

78.

American Diabetes Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596–601.

79.

Hasnain M, Vieweg WVR. Weight considerations in psychotropic drug prescribing and switching. Postgrad Med. 2013;125(5):117–29.PubMed

80.

Grossman DC, Bibbins-Domingo K, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, et al. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(23):2417–26.PubMed

81.

Berkowitz RI, Rukstalis MR, Bishop-Gilyard CT, Moore RH, Gehrman CA, Xanthopoulos MS, et al. Treatment of adolescent obesity comparing self-guided and group lifestyle modification programs: a potential model for primary care. J Pediatr Psychol. 2013;38(9):978–86.PubMedPubMedCentral

82.

Teasdale SB, Ward PB, Rosenbaum S, Samaras K, Stubbs B. Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry. 2016;210(2):110–8.PubMed

83.

Naslund JA, Whiteman KL, McHugo GJ, Aschbrenner KA, Marsch LA, Bartels SJ. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2017;47:83–102.PubMedPubMedCentral

84.

• Teasdale SB, Ward PB, Rosenbaum S, Watkins A, Curtis J, Kalucy M, et al. A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis. Br J Nutr. 2016;115(11):1987–93 This study evaluated the feasibility and effectiveness of a 12-week nutrition intervention in participants ages 15–25 years with FEP.PubMed

85.

Ignaszewski MJ, Waslick B. Update on randomized placebo-controlled trials in the past decade for treatment of major depressive disorder in child and adolescent patients: a systematic review. J Child Adolesc Psychopharmacol. 2018;28:668–75.PubMed

86.

Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR. Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep. 2015;17(7):52.PubMed

87.

Stafford MR, Mayo-Wilson E, Loucas CE, James A, Hollis C, Birchwood M, et al. Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117166.PubMedPubMedCentral

88.

Goldstein BI, Sassi R, Diler RS. Pharmacologic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatric Clin. 2012;21(4):911–39.

89.

Haas M, Eerdekens M, Kushner S, Singer J, Augustyns I, Quiroz J, et al. Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study. Br J Psychiatry. 2009;194(2):158–64.PubMed

90.

Reyes M, Buitelaar J, Toren P, Augustyns I, Eerdekens M. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry. 2006;163(3):402–10.PubMed

91.

Chao AM, Wadden TA, Berkowitz RI. The safety of pharmacologic treatment for pediatric obesity. Expert Opin Drug Saf. 2018;17(4):379–85.PubMed

92.

Chanoine J-P, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873–83.PubMed

93.

de Silva VA, Suraweera C, Ratnatunga SS, Dayabandara M, Wanniarachchi N, Hanwella R. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016;16(1):341.PubMedPubMedCentral

94.

• Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry. 2006;163(12):2072–9 This is a small, 16-week placebo-controlled trial demonstating the safety and efficacy of metformin in youth taking second-generation antipsychotics.PubMed

95.

ClinicalTrials.gov. Metformin for overweight & obese children and adolescents with BDS treated with SGAs (MOBILITY). 2017. https://clinicaltrials.gov/ct2/show/NCT02515773. Accessed July 25 2018.

96.

Pratt JS, Lenders CM, Dionne EA, Hoppin AG, Hsu GL, Inge TH, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obesity. 2009;17(5):901–10.PubMed

97.

Herget S, Rudolph A, Hilbert A, Blüher S. Psychosocial status and mental health in adolescents before and after bariatric surgery: a systematic literature review. Obes Facts. 2014;7(4):233–45.PubMedPubMedCentral

98.

Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114(1):217–23.PubMed

99.

Mackey ER, Wang J, Harrington C, Nadler EP. Psychiatric diagnoses and weight loss among adolescents receiving sleeve gastrectomy. Pediatrics. 2018:e20173432.

100.

Njoroge WF, Hostutler CA, Schwartz BS, Mautone JA. Integrated behavioral health in pediatric primary care. Curr Psychiatry Rep. 2016;18(12):106.PubMed

101.

Hilt R, Marx L, Pierce K, Sarvet B, Becker E, Kendrick J et al. A guide to building collaborative mental health care partnerships in pediatric primary care. 2010.

Titel: Obesity in Adolescents with Psychiatric Disorders
verfasst von: Ariana M. Chao
Thomas A. Wadden
Robert I. Berkowitz
Publikationsdatum: 01.01.2019
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 1/2019
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-019-0990-7

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Sex Differences in Adolescent Anorexia and Bulimia Nervosa: Beyond the Signs and Symptoms

National Child Mental Health Quality Measures: Adherence Rates and Extent of Evidence for Clinical Validity

Psychosocial Interventions Targeting Social Functioning in Adults on the Autism Spectrum: a Literature Review

Evolving Models of Integrated Behavioral Health and Primary Care